<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03434392</url>
  </required_header>
  <id_info>
    <org_study_id>PRO17060648</org_study_id>
    <nct_id>NCT03434392</nct_id>
  </id_info>
  <brief_title>QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing</brief_title>
  <official_title>QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dhiraj Yadav</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aalborg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Quantitative Sensory Testing (QST) is a novel investigative technique used in other pain
      conditions to evaluate patterns of chronic pain, and in this study will be used to elucidate
      pain patterns in patients with Chronic Pancreatitis (CP). QST uses a specific series of
      standardized stimulations to map the pain system. QST has the potential to change and improve
      the treatment paradigm for patients with CP and may eventually be able to predict response to
      invasive CP therapies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In Chronic Pancreatitis (CP), clinical pain symptoms correlate poorly with pancreatic ductal
      morphology, response to endoscopic or surgical therapy is unpredictable, and the rationale
      for invasive therapies is often questioned. Quantitative sensory testing (QST) is a technique
      used to map the pain system based on the rationale that different neural pathways and
      networks can be explored using standardized stimulation and simultaneous recording of the
      evoked pain response by psychophysical and/or objective methods. In this study, the
      investigators aim to distinguish phenotypes characterized by segmental sensitization of the
      pancreatic viscerotome, and systemic sensitization with pathological central pain processing.

      The investigators will perform QST on controls and CP subjects consisting of stimulation in
      several different dermatomes including pancreatic and control areas. All subjects will also
      answer standardized questionnaires assessing pain, depression, anxiety, and quality of life
      at baseline. Subjects undergoing endoscopic or surgical therapy will also undergo follow-up
      testing consisting of the same tests at 1, 3, and 6 months post-procedure for evaluation of
      changes in their pain profile.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 24, 2017</start_date>
  <completion_date type="Anticipated">November 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants are assigned to one of four groups in parallel for the duration of the study based on prior clinical history.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Pattern Assessment as assessed by the combination of Temporal Summation score, Sensitization score, and Conditioned Pain Modulation score</measure>
    <time_frame>One-time baseline testing</time_frame>
    <description>Assignment to one of Four Groups (Segmental Sensitization, Systemic Sensitization, Impaired Conditioned Pain Modulation, or Other) based on combination of Temporal Summation score, Sensitization score, and Conditioned Pain Modulation score to be recorded in all patients on enrollment. Patients will be grouped according to whether these scores are inside or outside of 95% Confidence Interval of Mean Scores of Control patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Mean Pain score</measure>
    <time_frame>90 days</time_frame>
    <description>In Definite CP Patients undergoing endotherapy as part of regular clinical care, assessment of mean pain level for 7 days prior to endotherapy will be assessed immediately pre-procedure and again at 90 days post-procedure. A pain reduction of &gt;30% in 90 days after procedure will be characterized as positive response to procedure.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Chronic Pancreatitis</condition>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects with no pancreatic disease and no abdominal pain.
Subjects will undergo the following Interventions: QST tests 1, 2, and 3.
They will also fill out validated questionnaires.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Suspected CP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Suspected Chronic Pancreatitis patients.
Subjects will undergo the following Interventions: QST tests 1, 2, and 3.
They will also fill out validated questionnaires.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Definite CP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Definite Chronic Pancreatitis patients.
Subjects will undergo the following Interventions: QST tests 1, 2, and 3.
They will also fill out validated questionnaires.
A subset of these patients who undergo endotherapy as per clinical recommendation from clinical provider independent of this study will be followed for 6 months after their clinical intervention for repeat QST tests 1, 2, and 3 and questionnaires.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sphincter of Oddi Dysfunction or Functional Dyspepsia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with Sphincter of Oddi Dysfunction Type 1 or Type 2, or who have a prior diagnosis of Functional Dyspepsia.
Subjects will undergo the following Interventions: QST tests 1, 2, and 3.
They will also fill out validated questionnaires.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Quantitative Sensory Test1</intervention_name>
    <description>Subject will give pain rating (on Visual Analogue Scale (VAS) 0-10) of single as well as multiple stimulation with round-tip non-invasive pin-prick device. Difference is recorded as Temporal Summation Score.</description>
    <arm_group_label>Healthy Controls</arm_group_label>
    <arm_group_label>Suspected CP</arm_group_label>
    <arm_group_label>Definite CP</arm_group_label>
    <arm_group_label>Sphincter of Oddi Dysfunction or Functional Dyspepsia</arm_group_label>
    <other_name>Temporal Summation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Quantitative Sensory Test 2</intervention_name>
    <description>Subject will state when they first detect pain and pain detection threshold in response to pressure administration with pressure algometer. Pressure threshold recorded in kilopascals(kP). Stimulation will be repeated in pancreatic and control dermatomes. Subject will then state pain tolerance threshold at same locations. Sensitization will be characterized by ratio of pancreatic vs. control dermatome scores.</description>
    <arm_group_label>Healthy Controls</arm_group_label>
    <arm_group_label>Suspected CP</arm_group_label>
    <arm_group_label>Definite CP</arm_group_label>
    <arm_group_label>Sphincter of Oddi Dysfunction or Functional Dyspepsia</arm_group_label>
    <other_name>Segmental v Systemic Sensitization</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Quantitatie Sensory Test 3</intervention_name>
    <description>Subject will apply dominant hand to ice-chilled water bath (36F) for up to 2 minutes. Pain score (VAS 0-10) will be assessed each 10 seconds. Pain tolerance threshold (in kP) will be assessed with algometer on non-dominant thigh before and after water bath to determine change in threshold. Difference in pain tolerance recorded as Conditioned Pain Modulation Score.</description>
    <arm_group_label>Healthy Controls</arm_group_label>
    <arm_group_label>Suspected CP</arm_group_label>
    <arm_group_label>Definite CP</arm_group_label>
    <arm_group_label>Sphincter of Oddi Dysfunction or Functional Dyspepsia</arm_group_label>
    <other_name>Conditioned Pain Modulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects with no pancreatic disease and no abdominal pain, or patients with a
             diagnosis of functional dyspepsia.

               -  Subjects are 18 years or older in age

               -  Subjects must be able to read and understand the study information.

               -  Personally signed and dated informed consent document indicating that the subject
                  has been informed of all pertinent aspects of the study.

               -  Subject is willing and able to comply with the scheduled visits, questionnaires,
                  treatment plan, and other study procedures.

          2. Suspected CPs Inclusion Criteria

               -  Subjects are 18 years or older in age

               -  Subjects with a) Indeterminate CP (Cambridge 1 or 2 on CT scan or MRI/MRCP) who
                  have abdominal pain without prior history of AP, or b) those with acute (AP) or
                  recurrent acute pancreatitis (RAP) who have recovered from their attack(s) of AP,
                  whose imaging studies are either normal or show changes consistent with Cambridge
                  classification of 1 or 2, and they have ongoing abdominal pain. Both diabetic and
                  non-diabetic subjects will be allowed to enter the study.

               -  Subjects must be able to read and understand the study information.

               -  Subjects must suffer from abdominal pain suspected to be pancreatic origin with
                  an intensity above 3 on the visual analogue scale (VAS, where 0=no pain and 10=
                  intolerable pain), and meet the criteria for chronic pain (pain â‰¥ 3 days per week
                  for at least 3 months).

               -  Personally signed and dated informed consent document indicating that the subject
                  has been informed of all pertinent aspects of the study.

               -  Subjects willing and able to comply with the scheduled visits, questionnaires,
                  and other study procedures.

          3. Definite Chronic Pancreatitis - Inclusion Criteria

               -  Subjects are 18 years or older in age

               -  Subjects will have a prior confirmed diagnosis of CP on CT scan or MRI/MRCP
                  according to Cambridge Classification (grade 3 or 4). Both diabetic and
                  non-diabetic subjects will be allowed to enter the study.

               -  Subjects must be able to read and understand the study information.

               -  Personally signed and dated informed consent document indicating that the subject
                  has been informed of all pertinent aspects of the study.

               -  Subjects willing and able to comply with the scheduled visits, questionnaires,
                  and other study procedures.

          4. Sphincter of Oddi Dysfunction (SOD) Type 1 or Type 2 Inclusion Criteria

               -  Subjects are 18 years or older in age

               -  Subjects have prior diagnosis of Type 1 or Type 2 Sphincter of Oddi Dysfunction
                  (subjects with biliary pain accompanied by biochemical features of transient
                  biliary tract obstruction including elevated transaminases, alkaline phosphatase,
                  or conjugated bilirubin; may also be accompanied by biliary or pancreatic ductal
                  dilation on imaging)

               -  Subjects must be able to read and understand the study information.

               -  Personally signed and dated informed consent document indicating that the subject
                  has been informed of all pertinent aspects of the study.

               -  Subjects willing and able to comply with the scheduled visits, questionnaires,
                  and other study procedures.

        Exclusion Criteria:

          1. Subjects with no pancreatic disease and no abdominal pain, or patients with a
             diagnosis of functional dyspepsia.

               -  Subjects with evidence or history of medical or surgical disease of importance
                  for this study as judged by investigator.

               -  Subjects suffering from painful conditions that make them unable to distinguish
                  the pain associated with CP from chronic pain of other origins.

               -  Subjects with known pregnancy at the time of enrolment.

               -  Subjects who have previously undergone surgical intervention on their pancreas.

          2. Suspected CPs Exclusion Criteria

               -  Subjects with evidence or history of medical or surgical disease of importance
                  for this study as judged by investigator.

               -  Subjects suffering from painful conditions other than pancreatitis or SOD type 1
                  or 2 that make them unable to distinguish the pain associated with pancreatitis
                  or SOD from chronic pain of other origins.

               -  Subjects with known pregnancy at the time of enrolment.

               -  Subjects who have previously undergone surgical intervention on their pancreas.

          3. Definite Chronic Pancreatitis Exclusion Criteria

               -  Subjects with evidence or history of medical or surgical disease of importance
                  for this study as judged by investigator.

               -  Subjects suffering from painful conditions other than pancreatitis or SOD type 1
                  or 2 that make them unable to distinguish the pain associated with pancreatitis
                  or SOD from chronic pain of other origins.

               -  Subjects with known pregnancy at the time of enrolment.

               -  Subjects who have previously undergone surgical intervention on their pancreas.

          4. Sphincter of Oddi Dysfunction (SOD) Type 1 or Type 2 Exclusion Criteria

               -  Subjects with evidence or history of medical or surgical disease of importance
                  for this study as judged by investigator.

               -  Subjects suffering from painful conditions other than pancreatitis or SOD that
                  make them unable to distinguish the pain associated with pancreatitis or SOD from
                  chronic pain of other origins.

               -  Subjects with known pregnancy at the time of enrolment.

               -  Subjects who have previously undergone surgical intervention on their pancreas.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dhiraj Yadav, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna E Phillips, MD</last_name>
    <phone>412-624-4560</phone>
    <email>evansac3@upmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laura Mathews</last_name>
    <phone>412-624-3096</phone>
    <email>ljm96@pitt.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna E Phillips, MD</last_name>
      <phone>412-624-4560</phone>
      <email>evansac3@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Anna E Phillips, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2017</study_first_submitted>
  <study_first_submitted_qc>February 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2018</study_first_posted>
  <last_update_submitted>February 8, 2018</last_update_submitted>
  <last_update_submitted_qc>February 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Dhiraj Yadav</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Chronic Pain</keyword>
  <keyword>Chronic Pancreatitis</keyword>
  <keyword>Sphincter of Oddi Dysfunction</keyword>
  <keyword>Recurrent Acute Pancreatitis</keyword>
  <keyword>Chronic Abdominal Pain</keyword>
  <keyword>Functional Dyspepsia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Pancreatitis, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

